Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4HEW2
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 280 | 284 | PF00656 | 0.592 |
CLV_C14_Caspase3-7 | 347 | 351 | PF00656 | 0.716 |
CLV_NRD_NRD_1 | 259 | 261 | PF00675 | 0.683 |
CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.683 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.317 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.730 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.518 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.460 |
DEG_SCF_FBW7_2 | 321 | 328 | PF00400 | 0.816 |
DEG_SCF_TRCP1_1 | 234 | 239 | PF00400 | 0.462 |
DOC_CKS1_1 | 322 | 327 | PF01111 | 0.741 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.744 |
DOC_USP7_MATH_1 | 311 | 315 | PF00917 | 0.718 |
DOC_USP7_MATH_1 | 331 | 335 | PF00917 | 0.755 |
DOC_USP7_MATH_1 | 346 | 350 | PF00917 | 0.635 |
DOC_USP7_MATH_1 | 96 | 100 | PF00917 | 0.485 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.741 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.601 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.452 |
LIG_14-3-3_CanoR_1 | 293 | 302 | PF00244 | 0.562 |
LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.454 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.509 |
LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.734 |
LIG_FHA_1 | 216 | 222 | PF00498 | 0.595 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.626 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.515 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.593 |
LIG_FHA_2 | 336 | 342 | PF00498 | 0.727 |
LIG_FHA_2 | 352 | 358 | PF00498 | 0.748 |
LIG_FHA_2 | 42 | 48 | PF00498 | 0.715 |
LIG_Integrin_RGD_1 | 198 | 200 | PF01839 | 0.544 |
LIG_LIR_Apic_2 | 117 | 121 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 241 | 247 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 283 | 289 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 42 | 46 | PF02991 | 0.607 |
LIG_LIR_Nem_3 | 90 | 94 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 98 | 103 | PF02991 | 0.513 |
LIG_PDZ_Class_3 | 360 | 365 | PF00595 | 0.784 |
LIG_SH2_CRK | 118 | 122 | PF00017 | 0.517 |
LIG_SH2_NCK_1 | 308 | 312 | PF00017 | 0.520 |
LIG_SH2_STAP1 | 308 | 312 | PF00017 | 0.579 |
LIG_SH2_STAT3 | 70 | 73 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 289 | 292 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 308 | 311 | PF00017 | 0.580 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.423 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.453 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.555 |
LIG_SUMO_SIM_par_1 | 150 | 156 | PF11976 | 0.648 |
LIG_TRAF2_1 | 360 | 363 | PF00917 | 0.514 |
LIG_WRC_WIRS_1 | 40 | 45 | PF05994 | 0.653 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.661 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.628 |
MOD_CK1_1 | 232 | 238 | PF00069 | 0.478 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.706 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.723 |
MOD_CK2_1 | 292 | 298 | PF00069 | 0.558 |
MOD_CK2_1 | 331 | 337 | PF00069 | 0.727 |
MOD_CK2_1 | 351 | 357 | PF00069 | 0.563 |
MOD_GlcNHglycan | 105 | 109 | PF01048 | 0.314 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.321 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.703 |
MOD_GlcNHglycan | 233 | 237 | PF01048 | 0.720 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.629 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.517 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.644 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.741 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.550 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.670 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.735 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.517 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.494 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.635 |
MOD_NEK2_2 | 300 | 305 | PF00069 | 0.502 |
MOD_PIKK_1 | 174 | 180 | PF00454 | 0.796 |
MOD_PIKK_1 | 69 | 75 | PF00454 | 0.449 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.440 |
MOD_PKB_1 | 196 | 204 | PF00069 | 0.544 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.542 |
MOD_Plk_1 | 331 | 337 | PF00069 | 0.543 |
MOD_Plk_2-3 | 215 | 221 | PF00069 | 0.534 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.743 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.604 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.455 |
MOD_SUMO_for_1 | 87 | 90 | PF00179 | 0.555 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.553 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.527 |
TRG_ER_diArg_1 | 258 | 260 | PF00400 | 0.660 |
TRG_ER_FFAT_2 | 303 | 314 | PF00635 | 0.517 |
TRG_Pf-PMV_PEXEL_1 | 288 | 292 | PF00026 | 0.620 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6I9 | Leptomonas seymouri | 58% | 100% |
A0A3Q8ICS1 | Leishmania donovani | 82% | 100% |
A0A422NSU1 | Trypanosoma rangeli | 44% | 100% |
A4I235 | Leishmania infantum | 82% | 100% |
E9AY85 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q988 | Leishmania major | 82% | 100% |